STOX1 and preeclampsia: Similar to other studies [3]–[5] challenging the role of STOX1 in preeclampsia, we sequenced 20 patients and 20 controls but could not find any association with the Y153H polymorphism described in the first study [1], neither find any transcriptional effects differentiating normal and pathological placentas (data not shown).